The osteogenic growth peptide (OGP) is a 14mer mitogen of osteoblastic
and fibroblastic cells. Physiologically, OGP is present in high abund
ance in human and other mammalian sera. Most of the serum OGP is compl
exed noncovalently to heat sensitive, high molecular weight OGP-bindin
g proteins (OGPBPs). Changes in serum OGP levels that follow bone marr
ow ablation and the low doses of exogenous OGP required for the stimul
ation of bone formation suggest a regulatory role for the OGPBPs. In t
he present work, the OGP binding activity was monitored by competitive
binding to [3-I-125(Tyr(10)]sOGP and the corresponding complexes were
demonstrated on nondenaturing cathodic polyacrylamide gel electrophor
esis. We show that OGP binds to both native and activated human plasma
alpha(2)-macroglobulin (alpha(2)M). alpha(2)M was also immunoidentifi
ed in reduced and nonreduced SDS-polyacrylamide gel electrophoresis of
OGP-affinity purified plasma-derived proteins; immunoreactive OGP was
detected in commercial preparations of both forms of alpha(2)M; OGP w
as purified to homogeneity from the commercia! preparation of activate
d alpha(2)M. In MC3T3 El cells, native alpha(2)M, at concentrations <5
0 ng/mL, had a substantially increased mitogenic effect in the presenc
e of synthetic, native-like, OGP (sOGP). Similar amounts of activated
alpha(2)M inhibited the sOGP proliferative effect, These results sugge
st that the native alpha(2)M enhances the immediate availability of OG
P to its target cells, Activated alpha(2)M may participate in the remo
val of OGP from the system.